Neogen (NEOG) Common Equity (2010 - 2026)

Neogen's Common Equity history runs 17 years deep, the most recent figure standing at $2.1 billion for Q1 2026.

• In Q1 2026, Common Equity fell 20.97% year-over-year to $2.1 billion; the TTM figure through Feb 2026 stood at $2.1 billion (down 20.97% YoY), while the FY2025 annual figure was $2.1 billion, down 34.13% from the prior year.
• Common Equity was $2.1 billion for Q1 2026 at Neogen, roughly flat from $2.1 billion in the prior quarter.
• In the past five years, Common Equity ranged from a high of $3.1 billion in Q4 2023 to a low of $875.5 million in Q1 2022.
• Historically, Common Equity has averaged $2.4 billion across 5 years, with a median of $2.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity surged 258.91% in 2022, then sank 34.13% in 2025.
• A 5-year view of Common Equity shows it stood at $3.1 billion in 2022, then advanced by 1.33% to $3.1 billion in 2023, then slipped by 15.2% to $2.7 billion in 2024, then fell by 21.15% to $2.1 billion in 2025, then declined by 0.1% to $2.1 billion in 2026.
• The last three Common Equity figures came in at $2.1 billion (Q1 2026), $2.1 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.